Inflammaging, immunosenescence, and cardiovascular aging: insights into long COVID implications
對不起,此内容只適用於English。By Ludmila Müller et al. Source Frontiers Aging leads to physiological changes, including inflammaging—a chronic low-grade...
對不起,此内容只適用於English。By Ludmila Müller et al. Source Frontiers Aging leads to physiological changes, including inflammaging—a chronic low-grade...
對不起,此内容只適用於English。By Sunyoung Kim et al. Source Nature Abstract We investigated whether SARS-CoV-2 infection is associated with short- and...
對不起,此内容只適用於English。By F. Perry Wilson Source Medscape This transcript has been edited for clarity. Welcome to Impact Factor, your weekly dose of...
對不起,此内容只適用於English。By A. R. Bland et al. Source Nature Post-COVID Syndrome has emerged as a significant public health concern worldwide with...
對不起,此内容只適用於English。By Miriam E. Tucker Source Medscape A new broadly inclusive definition of long COVID from the National Academies of Sciences,...
對不起,此内容只適用於English。By Oscar Perez et al. Source sciencedirect Abstract Objective To characterize long-term patient-reported symptoms and quality of...
對不起,此内容只適用於English。By Fathima Humaira Amanullah et al. Source Frontiers The global impact of the SARS-CoV-2 pandemic has been unprecedented, posing...
對不起,此内容只適用於English。By Kristina Fiore Source Medpagetoday A 15-day course of the antiviral nirmatrelvir-ritonavir (Paxlovid) didn't improve symptoms...
對不起,此内容只適用於English。By Linda N. Geng et al. Source Jamanetwork Key Points Question What is the efficacy of 15 days of nirmatrelvir-ritonavir for...
對不起,此内容只適用於English。By Miao Cai et al. Source Nature Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes...